A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT02725515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the ability of XmAb5871 to maintain Systemic Lupus Erythematosus (SLE) disease activity improvement achieved by a brief course of disease-suppressing steroid therapy
Study identification
- NCT ID
- NCT02725515
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2016
- Primary completion
- Jul 16, 2018
- Completion
- Jul 16, 2018
- Last update posted
- Aug 19, 2019
2016 – 2018
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC San Diego | La Jolla | California | 92037 | — |
| Loma Linda University | Loma Linda | California | 92354 | — |
| East Bay Rheumatology Medical Group | San Leandro | California | 94578 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06250 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Center For Rheumatology | Fort Lauderdale | Florida | 33309 | — |
| Piedmont Atlanta Rheumatology | Atlanta | Georgia | 30309 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Joshua P June, DO | Lansing | Michigan | 48910 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Suny Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Feinstein Institute for Medical Research | Manhasset | New York | 11030 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Columbia University Medical Center | The Bronx | New York | 10461 | — |
| CTRC University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27517 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210 | — |
| Paramount Medical Research and Consulting LLC | Cleveland | Ohio | 44130 | — |
| Arthritis & Rheumatology Center of Oklahoma, PLLC | Oklahoma City | Oklahoma | 73103 | — |
| Oklahoma Center for Arthritis Therapy & Research | Tulsa | Oklahoma | 74104 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02725515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2019 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02725515 live on ClinicalTrials.gov.